Coherus Biosciences Inc.
[WKN: A12ETZ | ISIN: US19249H1032]
Aktienkurse
0,783€ 5,84%
Echtzeit-Aktienkurs Coherus Biosciences Inc.
Bid: Ask:
Reuters Kategorien
dpa-AFX Compact / dpa-AFX PRO Kategorien
Traderfox: dpa-AFX ProFeed Kategorien
dpa-AFX ProFeed Kategorien

Coherus to Acquire Surface Oncology

– Surface acquisition and potential toripalimab approval will transform Coherus into an I-O company with multiple next-generation immunotherapies in clinical…